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  As per the World Health Organization (WHO), a total of 100 
tropical and subtropical countries are endemic for dengue, 
India being one of them[1]. Due to the severe complications 
involved, non-availability of an effective preventive 
measure in the form of vaccination and the patient 
management relying largely on good supportive care, there 
are enough reasons explaining the importance of early and 
accurate diagnosis of dengue. The mainstay for diagnosis is 
serological detection of nonstructural protein 1 (NS1) antigen 
and antibodies against dengue. However, both the assays 
have their pros and cons.
  NS1 is essential for viral replication hence the amount 
of secreted NS1 (sNS1) in the serum of patients directly 
correlates with viremia[2]. NS1Ag has been detected in the 
blood circulation as early as viral RNA therefore the NS1 
Ag assays have the advantage of being positive as early 
as the first day of fever. Moreover, the detection does not 
appear to be hindered by the presence of anti-dengue IgM 
antibodies[3]. NS1Ag assays due to high specificity can 
also help in serotype determination. Thus for all practical 
purposes, it is an easy, fast and feasible alternative to RT-
PCR in developing countries, for making an early dengue 
diagnosis[4]. On the other side, overall sensitivity of NS1 
Ag detection kit varies widely across the various forms of 
dengue infection[5], being most sensitive in dengue type 
1 infection only. Further, sensitivity is also affected by 
the day of infection, found to be highest only in patients 
sampled during the first 9 days after onset of fever[6,7]. It is 
also less in patients with primary infection and in DF rather 
than DHF/DSS. The levels vary significantly depending upon 
the individual affected, phenotype of the virus and storage 
conditions after sample collection[8].
  Considering other option, detecting the antibodies 
particularly IgM, takes minimum of 10-12 days to come 
positive and the elevated IgM in a sample could be the 
result of an infection that occurred 2 to 3 months ago[9,10]. 
In addition, there is cross reactivity with the infections 
caused by other flaviviruses including West Nile virus, St. 
Louis encephalitis virus[11,12], Japanese encephalitis virus 
and yellow fever virus. Further, IgM levels are significantly 
lower in secondary dengue infections and thus some false-
negative reactions can be observed during secondary 
infections[13,14]. However, in endemic countries, subclinical 
infections are common. As a result, patient may fail to 
present within the first few days of illness (the time period 
for maximum NS1Ag serologic detection), then, it is the IgM 
antibody detection which clinches the diagnosis.
  In our centre, a total of 844 blood samples were received 
in the Department of Microbiology from clinically suspected 
dengue cases from July 2011 to December 2011. The sera 
were separated and the test was put up for detection of 
dengue IgM antibodies and NS1Ag by PanBio ELISA, 
supplied by Inverness Medical Innovations Australia 
Private Limited, Australia. The test was performed as per 
the instructions of the manufacturer. Out of a total of 844 
samples, a total of 204 (24.17%) samples were positive for 
dengue virus infection. The month-wise details of these 
patients are given in Table 1.
  A careful evaluation of data shows that if we had performed 
only dengue IgM ELISA, we would have reported only 157 
samples positive for dengue IgM antibodies and would have 
missed 78 (38%) cases. Similarly, if we had performed only 
NS1Ag ELISA, we would have reported only 126 samples 
positive and would have missed 47 (23%) other cases 
positive for dengue NS1Ag. So, by putting up both the tests 
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on each sample received, we could pick substantial number 
of additional cases positive for dengue virus infection. 
If this is the scenario in one institution in one region, 
considering the whole country/ endemic regions worldwide, 
the epidemiological significance of this finding can not 
be ignored. We all are well aware of the importance of 
determining the full burden of dengue virus infection which 
can help in guiding public health policies, implementing 
vector control measures especially household contacts 
and the need for development of vaccines and antivirals to 
curtail the disease. Considering the disease a public health 
priority, to determine the true prevalence of the disease, it is 
advocated that both assays ie. determination of NS1 Ag and 
IgM antibodies should be performed simultaneously on the 
given sample.
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Table 1
Month-wise details of the cases positive for dengue virus infection.
Month(Total samples positive /Total 
samples)
OnlyIgM positive/Total IgM 
positive
Only NS1Ag positive/ Total NS1Ag 
positive
Both IgM and NS1Ag positive
July 2011 (1/24) 0/1 0/1   1
August 2011(2/60) 1/1 1/1   0
September 2011(16/117)  6/11   5/10   5
October 2011 (120/346) 44/95 25/76 51
November 2011(54/151)  22/ 41 13/32 19
December 2011(11/46) 5/8 3/6   3
Total (204/844)   78/157   47/126 79
